Kiniksa Pharmaceuticals International, plc Other Current Liabilities
Kiniksa Pharmaceuticals International, plc (KNSA) had Other Current Liabilities of $20.69 million as of 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-04-28
- 2026-03-31: Other Liabilities, Current $20.69M.
- 2025-12-31: Other Liabilities, Current $22.13M.
- 2025-09-30: Other Liabilities, Current $20.52M.
- 2025-06-30: Other Liabilities, Current $18.00M.
| Period end | Other Liabilities, Current |
|---|---|
| 2026-03-31 | $20.69M 10-Q · filed 2026-04-28 |
| 2025-12-31 | $22.13M 10-Q · filed 2026-04-28 |
| 2025-09-30 | $20.52M 10-Q · filed 2025-10-28 |
| 2025-06-30 | $18.00M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $17.09M 10-Q · filed 2025-04-29 |
| 2024-12-31 | $16.08M 10-K · filed 2026-02-24 |
| 2024-09-30 | $16.07M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $11.48M 10-Q · filed 2024-07-25 |
| 2024-03-31 | $11.43M 10-Q · filed 2024-04-25 |
| 2023-12-31 | $8.19M 10-K · filed 2025-02-25 |
| 2023-09-30 | $6.43M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $4.60M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $4.33M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $5.75M 10-K · filed 2024-02-28 |
| 2022-09-30 | $8.79M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $3.19M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $4.77M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $1.54M 10-K · filed 2023-03-02 |
| 2021-09-30 | $1.00M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $926.00K 10-Q · filed 2021-08-05 |
| 2020-12-31 | $37.00K 10-K · filed 2022-02-24 |
| 2019-12-31 | $25.00K 10-K · filed 2021-02-25 |
| 2019-06-30 | $165.00K 10-Q · filed 2019-08-13 |
| 2018-12-31 | $218.00K 10-K · filed 2020-03-05 |